Ezetimibe and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Ibrance (palbociclib). Common drug interactions include alopecia among females and affective disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Ibrance. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

On Jul, 08, 2026

87 people who take Ezetimibe and Ibrance together, and have interactions are studied.

Ezetimibe and Ibrance drug interactions.

What are the common drug interactions of Ezetimibe and Ibrance, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Neoplasm progression (growth of tumour)
Red blood cell count decreased
Arthralgia (joint pain)
Decreased appetite
Diarrhoea
Weight decreased
Haemoglobin decreased
Nausea (feeling of having an urge to vomit)
Asthenia (weakness)

male:

Affective disorder (mental disorder)
Deafness
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the common drug interactions of Ezetimibe and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Metastases to bone (cancer spreads to bone)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
White blood cell count decreased
Wound

50-59:

Skin infection
Arthralgia (joint pain)
Back pain
Blood potassium decreased
Sinusitis (inflammation of sinus)
Affective disorder (mental disorder)
Alopecia (absence of hair from areas of the body)
Bone disorder
Cataract (clouding of the lens inside the eye)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

60+:

Fatigue (feeling of tiredness)
Thrombocytopenia (decrease of platelets in blood)
Weight decreased
Haemoglobin decreased
Nausea (feeling of having an urge to vomit)
Neoplasm progression (growth of tumour)
Diarrhoea
Asthenia (weakness)
Arthralgia (joint pain)
Death

What are the existing conditions these people have? *

Breast Cancer Female: 32 people, 36.78%
Breast Cancer: 28 people, 32.18%
Pain: 11 people, 12.64%
High Blood Pressure: 11 people, 12.64%
Breast Cancer Metastatic: 10 people, 11.49%
Lipid Metabolism Disorder (genetic disorders are caused by errors in fatty acid metabolism): 9 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously